Investigator
Assistant Director, Translational Operations, SMMART Program · Oregon Health & Science University, Knight Cancer Institute
Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression
Case report of a HER2-expressed ovarian clear cell carcinoma with exceptional response to trastuzumab deruxtecan.
Assistant Director, Translational Operations, SMMART Program
Oregon Health & Science University · Knight Cancer Institute
Senior Scientist, Cancer Biology, SMMART Program
National Institutes of Health · National Cancer Institute
Instructor
Dana-Farber Cancer Institute · Medical Oncology
Post-Doctoral Fellowship
Salk Institute for Biological Studies · Gene Expression Laboratory
Ph.D.
University of California San Diego · Biology
B.S.
University of Washington · Cell and Molecular Biology
US
